Rosana Kapeller
President and CEO of ROME Therapeutics
Cambridge, Massachusetts
Overview
Work Experience
President and CEO
2020 - Current
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Raised $199,000,000.00 from Mass General Brigham Ventures, Casdin Capital, Section 32, Curie.Bio, Sanofi Ventures, Google Ventures, Mirae Asset Capital, Luma Group, Axon Ventures and Andreessen Horowitz.
EIR
2018
Google Ventures is an investment arm of Alphabet that provides seed, venture, and growth-stage funding to technology companies.
Biotech executive
2018 - 2018
CSO
2010 - 2018
Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.
Raised $637,000,000.00 from Biotechnology Value Fund, RA Capital Management, Gates Frontier Fund, SR One, Pfizer Venture Investments, Bain Capital Life Sciences, Atlas Venture, Google Ventures, SV Health Investors and Lightstone Ventures.
Consultant
2009 - 2010
Vice President of Research
2005 - 2009
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.
Raised $256,212,894.00 from Nantahala Capital Management and Bios Partners.
Director
2002 - 2005
Scientist/ Sr. Scientist
1996 - 2002